Scopio Labs key facts
as of Oct 2026- Developer of a computational microscope and diagnostics equipment designed for easy and wide access to microscopy and diagnostics.
- Scopio Labs is valued at approximately $85.3M as of Oct 2026 (last reported valuation).
- It has raised $154.1M.
- Notable investors include European Commission, OurCrowd, GlenRock Israel, Insight Capital Partners, Arbelon Holdings — 19 tracked in total.
- Status: Privately Held (backing).
Scopio Labs's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·The complete investor list: 19 names
- ·Watch Scopio Labs: the Monday email on marks, rounds and moves
Scopio Labs funding rounds
No funding rounds for Scopio Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Scopio Labs
19+Membership and data by Private Market View
Scopio Labs valuation
Scopio Labs's last reported valuation was $85.3 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
Scopio Labs investors
19 investors are on record for Scopio Labs, including European Commission, OurCrowd, GlenRock Israel and Insight Capital Partners.
About Scopio Labs
Developer of a computational microscope and diagnostics equipment designed for easy and wide access to microscopy and diagnostics. The company's equipment offers a suite of fully digital diagnostic applications and imaging platforms that enhance clinical workflows with proper detection and diagnosis of blood-related diseases, enabling hematology labs to assess and analyze cell morphology at depth, making the diagnosis process more efficient and consistent across the continuum of care.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2014
- Employees
- 157
- Website
- scopiolabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.